Elicitation of efficient, protective immune responses by using DNA vaccines against tuberculosis (Q46673572)

24 December 2017

title

Elicitation of efficient, protective immune responses by using DNA vaccines against tuberculosis (English)

1 reference

24 December 2017

1 reference

Aparna Khera

1

1 reference

24 December 2017

Ramandeep Singh

2

1 reference

24 December 2017

H Shakila

3

1 reference

24 December 2017

Vivek Rao

4

1 reference

24 December 2017

Neeraj Dhar

5

1 reference

24 December 2017

P R Narayanan

6

1 reference

24 December 2017

C N Parmasivan

7

1 reference

24 December 2017

V D Ramanathan

8

1 reference

24 December 2017

Anil K Tyagi

9

1 reference

24 December 2017

language of work or name

English

0 references

publication date

1 August 2005

1 reference

24 December 2017

published in

Vaccine

1 reference

24 December 2017

volume

23

1 reference

24 December 2017

issue

48-49

1 reference

24 December 2017

page(s)

5655-5665

1 reference

24 December 2017

Tuberculosis vaccine development: recent progress

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.056

On the use of DNA vaccines for the prophylaxis of mycobacterial diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.056

Effect of mycobacterium bovis (BCG) infection on the kinetics of the mononuclear cell response within the lung

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.056

The relationship of delayed hypersensitivity to acquired cellular resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.056

Protective immunity against tuberculosis induced by vaccination with major extracellular proteins of Mycobacterium tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.056

Immunization of mice with mycobacterial culture filtrate proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.056

Comparison of antigen-specific T-cell responses of tuberculosis patients using complex or single antigens of Mycobacterium tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.056

Human T- and B-cell reactivity to the 16kDa alpha-crystallin protein of Mycobacterium tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.056

Recombinant BCG approach for development of vaccines: cloning and expression of immunodominant antigens of M. tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.056

DNA vaccination against tuberculosis: expression of a ubiquitin-conjugated tuberculosis protein enhances antimycobacterial immunity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.056

DNA vaccine combinations expressing either tissue plasminogen activator signal sequence fusion proteins or ubiquitin-conjugated antigens induce sustained protective immunity in a mouse model of pulmonary tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.056

The Mycobacterium tuberculosis recombinant 27-kilodalton lipoprotein induces a strong Th1-type immune response deleterious to protection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.056

Protection of mice with a divalent tuberculosis DNA vaccine encoding antigens Ag85B and MPT64.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.056

Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.056

CpG-containing synthetic oligonucleotides promote B and cytotoxic T cell responses to protein antigen: a new class of vaccine adjuvants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.056

A Toll-like receptor recognizes bacterial DNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.056

Enhanced murine antigen-specific gamma interferon and immunoglobulin G2a responses by using mycobacterial ESAT-6 sequences in DNA vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.056

Immunostimulatory DNA sequences necessary for effective intradermal gene immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.056

Disruption of response regulator gene, devR, leads to attenuation in virulence of Mycobacterium tuberculosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.056

Iron-cofactored superoxide dismutase inhibits host responses to Mycobacterium tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.056

The immunogenicity of single and combination DNA vaccines against tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.056

Effective vaccination of mice against Mycobacterium tuberculosis infection with a soluble mixture of secreted mycobacterial proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.056

7 January 2021

Immunization with extracellular proteins of Mycobacterium tuberculosis induces cell-mediated immune responses and substantial protective immunity in a guinea pig model of pulmonary tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.056

7 January 2021

Characterization of the major membrane protein of virulent Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.056

7 January 2021

Mycobacterial stationary phase induced by low oxygen tension: cell wall thickening and localization of the 16-kilodalton alpha-crystallin homolog.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.056

7 January 2021

Bacterial adaptation to oxidative stress: implications for pathogenesis and interaction with phagocytic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.056

7 January 2021

Influenza virus nucleoprotein-specific immunoglobulin G subclass and cytokine responses elicited by DNA vaccination are dependent on the route of vector DNA delivery

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.056

7 January 2021

10.1016/J.VACCINE.2005.03.056

Identifiers

DOI

1 reference

24 December 2017

PubMed ID

16157425

1 reference

24 December 2017